USD
$0.00
(0.00%
)At Close (As of Sep 3, 2025)
$11.96M
Market Cap
-
P/E Ratio
-18.93
EPS
$28.60
52 Week High
$4.91
52 Week Low
TRADE & SERVICES
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$10M |
Selling General And Administrative | $4.1M |
Research And Development | $6M |
Operating Expenses | $10M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$9.8M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9.8M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$10M |
Net Income | -$9.8M |
Field | Value (USD) |
---|---|
Total Assets | $4.7M |
Total Current Assets | $2.6M |
Cash And Cash Equivalents At Carrying Value | $2.3M |
Cash And Short Term Investments | $2.3M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $2.1M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2M |
Intangible Assets Excluding Goodwill | $2M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $0 |
Other Current Assets | $219K |
Other Non Current Assets | - |
Total Liabilities | $1.8M |
Total Current Liabilities | $1.8M |
Current Accounts Payable | $1.7M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $35K |
Total Non Current Liabilities | $69K |
Capital Lease Obligations | $104K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $104K |
Other Current Liabilities | $58K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $2.9M |
Treasury Stock | - |
Retained Earnings | -$50M |
Common Stock | $3K |
Common Stock Shares Outstanding | $3.2M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$8.4M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | - |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $7.8M |
Cashflow From Financing | $112K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$9.8M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$10M |
Selling General And Administrative | $4.1M |
Research And Development | $6M |
Operating Expenses | $10M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$9.8M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9.8M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$10M |
Net Income | -$9.8M |
Sector: TRADE & SERVICES
Industry: SERVICES-BUSINESS SERVICES, NEC
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.